LOAN RETCHLESS: Open Payments
NPI 1295784262 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 25 payments from 10 companies in 2025. Trend: 2023 $5,732 · 2024 $4,015 · 2025 $1,174
Food & beverage: $1,174
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 3 | $285 |
| E.R. Squibb & Sons, L.L.C. | 5 | $163 |
| Stemline Therapeutics Inc. | 3 | $146 |
| Astellas Pharma US Inc | 3 | $146 |
| ADC THERAPEUTICS AMERICA, INC. | 4 | $126 |
| Incyte Corporation | 1 | $125 |
| ABBVIE INC. | 1 | $95 |
| TAIHO ONCOLOGY, INC. | 3 | $58 |
| Novocure Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: TEVIMBRA, Vyloy, OPDIVO, ZYNLONTA, Monjuvi, Orserdu, EMRELIS, LONSURF.
Industry payments across WA — which companies pay providers there.
